Latest Breaking News On - Precision medicines - Page 30 : comparemela.com

ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesSarah kielyHans vitzthumRobert stanislaroGerard platenburgExchange commissionEditing technologies for precision medicinesPeptide therapeuticsEditing technologiesPrecision medicinesChief innovation officerOligonucleotide discoveryAdenosine deaminase actingGlobe newswire

Praxis Precision Medicines (PRAX) Reports Positive Topline Results from PRAX-944 Phase 2a Study

Praxis Precision Medicines (PRAX) Reports Positive Topline Results from PRAX-944 Phase 2a Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shan kuoPatrick mccartneyBernard ravinaInternational essential tremor foundationInitiative for columbia ataxiaPrecision medicinesModified activitiesDaily livingSheng han kuoColumbia ataxiaAdverse eventsEmergent adverse eventsInternational essential tremor

Praxis Precision Medicines to Provide Corporate Update and Report First Quarter 2022 Financial Results on Monday, May 9, 2022

Praxis Precision Medicines to Provide Corporate Update and Report First Quarter 2022 Financial Results on Monday, May 9, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIan stone canale communicationsPraxis precision medicines incPrecision medicinesWebcast detailsCanada toll freePraxispraxis precision medicinesAlex kane praxis precision medicinesPraxis precision medicines

Praxis Precision Medicines to Provide Corporate Update and Report First Quarter 2022 Financial Results on Monday, May 9, 2022

02.05.2022 - BOSTON, May 02, 2022 (GLOBE NEWSWIRE) - Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders .

United statesPraxis precision medicines incPrecision medicinesWebcast detailsCanada toll free

Praxis Precision Medicines (PRAX) to Showcase Targeted Epilepsy Portfolio

Praxis Precision Medicines (PRAX) to Showcase Targeted Epilepsy Portfolio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMarcio souzaPraxis precision medicines incDrug administrationPrecision medicinesNew york cityInvestigational new drugTuberous sclerosis complex